reviewInternational Journal of Clinical PracticeOct 14, 2011BRONZE OA

Characterising the castration-resistant prostate cancer population: a systematic review

The Prostate Centre · AstraZeneca (United Kingdom) · +3 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Background

Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer associated with poor survival rates. However, characterisation of the disease epidemiology is hampered by use of varying terminology, definition and disease management. The aim of this review was to conduct a systematic review to provide greater clarity on the sum of the available epidemiologic evidence and to guide future research into the disease prevalence, progression, characteristics and outcome.

Methods

Systematic searches of PubMed and Embase were performed in March 2010 to identify relevant observational studies relating to the epidemiology, progression and outcomes of CRPC. Further studies were identified for inclusion in our review through manual searches of the authors' bibliographical databases and the reference lists of the included articles.

Citation impact

859
total citations
FWCI
16.06
Percentile
100%
References
27
Citations per year

Authors

3

Topics & keywords

Keywords
  • Medicine
  • Prostate cancer
  • Oncology
  • Gynecology
  • MEDLINE
  • Castration
  • Population
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding